Postprandial ghrelin response is reduced in patients with Parkinson’s disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson’s disease?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Ghrelin, an orexigenic peptide, has multiple functions, which include promoting gastrointestinal motility and influencing higher brain functions. Experimental data suggest that ghrelin has neuroprotective potential in the MPTP mouse model of Parkinson’s disease (PD). PD patients show delayed gastric emptying and other symptoms that may relate to disturbed excretion of ghrelin. No data are available on postprandial ghrelin response in patients with PD and idiopathic REM sleep behaviour disorder (iRBD)––a condition considered a putative preclinical stage of PD. We measured fasting and postprandial ghrelin serum concentrations in 20 healthy controls, 39 (including 19 drug-naïve) PD patients and 11 iRBD patients using a commercial radioimmunoassay for total ghrelin. For statistical analysis we employed ANCOVA and post-hoc testing with Bonferroni’s method. Controls showed a decrease of mean fasting ghrelin serum concentrations in the early postprandial phase, followed by a recuperation starting 60 min after the test meal and reaching a maximum at 300 min. This recuperation was less pronounced in PD and iRBD; the slope of relative postprandial ghrelin recovery was different between the investigated groups (p = 0.007). Post-hoc testing showed a difference between controls and PD patients (p = 0.002) and between controls and iRBD patients (p = 0.037). The dynamic regulation of ghrelin in response to food intake is partially impaired in subjects at putative preclinical (iRBD) and clinical stages of PD. Reduced ghrelin excretion might increase the vulnerability of nigrostriatal dopaminergic neurons as suggested by animal studies. The impaired ghrelin excretion might qualify as a peripheral biomarker and be of diagnostic or therapeutic value.
- Postprandial ghrelin response is reduced in patients with Parkinson’s disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson’s disease?
Journal of Neurology
Volume 258, Issue 6 , pp 982-990
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Parkinson’s disease
- REM sleep behaviour disorder (RBD)
- Vagal innervation, biomarker
- Industry Sectors
- Author Affiliations
- 1. Department of Neurology, Philipps-Universität Marburg, Rudolf-Bultmann-Strasse 8, 35033, Marburg, Germany
- 2. Neurocentro della Svizzera Italiana, Clinical Trials Unit, Ospedale Regionale di Lugano, Via Tesserete 46, 6903, Lugano, Switzerland
- 3. Division of Gastroenterology, Philipps-University Marburg, Marburg, Germany
- 4. Division of Endocrinology and Diabetology, Philipps-University Marburg, Marburg, Germany
- 5. Department of Neurology, Hephata-Clinic Schwalmstadt-Treysa, Schwalmstadt-Treysa, Germany
- 6. Deparment of Internal Medicine, Division of Gastroenterology, Klinikum Lippe, Detmold, Germany